Brigette Bard is the founder and CEO of BioSure UK. She is passionate about the role self testing has to play in allowing people to make informed choices and assume responsibility for their own healthcare. She is actively and dynamically involved in normalising the conversation around HIV, breaking down stigma and nurturing understanding around confident sex and sexual health.
BioSURE has developed the first legally approved HIV self testing kit in the UK. The BioSURE HIV Self Test enables people to find out their HIV status at a time and place of their choosing. The BioSURE HIV Self test uses a very small amount of blood from a finger prick sample to detect the presence of HIV antibodies and is over 99.7% accurate. Their biggest achievement to date was developing the world’s first HIV self test to utilise blood. They gained a CE mark and launched in the UK in 2015.